Keyphrases
Lineage Plasticity
100%
MPP8
100%
Bladder Cancer
50%
First-in-class
50%
Epithelial-to-mesenchymal Transition
28%
CDH1
18%
Epigenetic Dysregulation
12%
Chromatin Regulation
12%
Advanced Bladder Cancer
12%
Epigenetics
12%
Year 2020
9%
Cancer Research
9%
Chromatin
9%
Transition Resistance
6%
Chromatin Epigenetics
6%
Vietnam War
6%
Metastatic Bladder Cancer
6%
War Exposure
6%
Developmental Therapeutics
6%
Mission Readiness
6%
Health Focus
6%
Target Validation
6%
First-in-human Clinical Trials
6%
Contaminated Drinking Water
6%
Epigenetic Modification
6%
Cisplatin
6%
Metastasizing
6%
Chemical Biology
6%
Medicine and Dentistry
Bladder Cancer
100%
Mesenchymal-Epithelial Transition
50%
Epigenomics
22%
Disease
16%
Cancer Research
16%
Malignant Neoplasm
16%
Cisplatin
11%
Tobacco Use
5%
Hematologic Malignancy
5%
Cancer
5%
Solid Malignant Neoplasm
5%
Genetic Code
5%
Regulator Protein
5%
Translational Research
5%
Clinical Trial
5%
Health System
5%
Metastatic Bladder Cancer
5%
Pediatrics
5%
Bladder
5%
2,4,5 Trichlorophenoxyacetic Acid
5%
Cancer Therapy
5%
Tumor Suppressor Gene
5%
Metastatic Carcinoma
5%
Cancer Resistance
5%
Military Health
5%
Oncology
5%
Nodular Melanoma
5%
Infancy
5%
Overall Survival
5%
Muscle Invasive Bladder Cancer
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Malignant Neoplasm
36%
Disease
15%
Cisplatin
10%
Chemotherapy
10%
Melanoma
5%
Agent Orange
5%
Regulator Protein
5%
Muscle Invasive Bladder Cancer
5%
Tumor Suppressor Protein
5%
Clinical Trial
5%
Overall Survival
5%
Solid Malignant Neoplasm
5%
Hematologic Malignancy
5%
Pharmaceutical Chemistry
5%
Cancer Resistance
5%
Drug Development
5%